Market Overview:
The global Shuanghuanglian preparations market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of respiratory diseases, growing geriatric population, and rising demand for novel therapies. Based on type, the Shuanghuanglian preparations market can be segmented into oral solution, capsule, lozenges, chewable tablets, aerosol, injection, pills and particles. Oral solution is expected to account for the largest share of the market in 2018 owing to its high usage rates across all age groups. Capsule is projected to be the fastest-growing segment during the forecast period due to its advantages such as ease of use and long shelf life. Based on application, adult accounted for majority share of this market in 2017 while children’s application is projected grow at highest CAGR over next decade owing higher incidence rate pediatric respiratory diseases globally .
 Preparations Industry Outlook.svg)
Product Definition:
Shuanghuanglian (SHL) Preparations are the most effective preparations for improving blood circulation and removing blood stasis. They are also used to treat diseases such as coronary heart disease, cerebral thrombosis, and chronic hepatitis.
Shuanghuanglian Oral Solution:
Shuanghuanglian (SHL) oral solution is a combination of amino acids, vitamins and minerals that are necessary for the growth of cells in the body. It also helps to improve immune system response and enhance bone health. The product consists of 2-3% SHL by weight, which is usually taken in daily doses with water or milk.
Shuanghuanglian Capsule:
Shuanghuanglian capsule is a traditional Chinese medicine that has been used to treat stomach ulcers, skin diseases and cancer. It is also useful in treating women's problems such as menorrhagia (excessive bleeding during menstrual cycle), anemia, dysmetabolic syndrome X and endometriosis.
Application Insights:
The application of shuanghuanglian for the treatment of children was the largest segment in 2017. This is due to increasing number of parents opting for homeopathic treatment over conventional medical treatments for their children. Furthermore, growing awareness about health and wellness among adults is also expected to drive this segment during the forecast period.
Shuanghuanglian oral solution, capsule, chewable tablet and aerosol are widely used for treating adult ailments respectively whereas pills are preferred by pediatric patients suffering from coughs & colds as well as gastrointestinal conditions.
Regional Analysis:
Asia Pacific dominated the global shuanghuanglian preparations market in 2017. The presence of a large number of key players and increasing demand for herbal medicines are some factors contributing to the region’s growth. In addition, China is one of the largest consumers of traditional Chinese medicine (TCM) products globally, which has led to increased product penetration in this country over the years.
The Asia Pacific market was valued at USD X million in 2017 and is expected to witness significant growth over the forecast period owing to rising disposable income levels and improving healthcare infrastructure coupled with an increase in consumer awareness about modern medical treatments & alternatives such as SHL preparations that offer effective treatment for various diseases without any harmful effects or drug interactions associated with them compared to synthetic drugs used today.
Growth Factors:
- Increasing demand from the geriatric population: The global geriatric population is expected to grow at a CAGR of 6.5% from 2016 to 2020, reaching 1.6 billion by 2020. This growing population is increasingly susceptible to chronic diseases such as cancer, Alzheimer’s disease, and heart disease, which will drive the demand for SHL preparations in the coming years.
- Rising awareness about the benefits of SHL preparations: There is a growing awareness among consumers about the health benefits of SHL preparations and their role in preventing chronic diseases. This is likely to drive demand for these products in the coming years.
- Growing popularity of natural remedies: Consumers are increasingly turning towards natural remedies for preventive healthcare, due to their perceived safety and efficacy over conventional medications. This trend is likely to benefit SHL preparations market growth in the coming years..
Scope Of The Report
Report Attributes
Report Details
Report Title
Shuanghuanglian (SHL) Preparations Market Research Report
By Type
Shuanghuanglian Oral Solution, Shuanghuanglian Capsule, Shuanghuanglian Lozenges, Shuanghuanglian Chewable Tablets, Shuanghuanglian Aerosol, Shuanghuanglian Injection, Shuanghuanglian Pills, Shuanghuanglian Particles, Shuanghuanglian Syrup
By Application
Adult, Children
By Companies
Ruige Pharmaceutical, TALOPH, Dongguan Asia Pharmaceutical, Harbin Pharmaceutical Group, Xinsheng Pharmaceutical, Jinjiu Pharmaceutical, Fusen Pharmaceutical, TASLY Holding, Harbin No.4 Traditional Chinese Medicine, ZBD Pharmaceutical, Xiren Pharmaceutical, Gerun Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
152
Number of Tables & Figures
107
Customization Available
Yes, the report can be customized as per your need.
Global Shuanghuanglian (SHL) Preparations Market Report Segments:
The global Shuanghuanglian (SHL) Preparations market is segmented on the basis of:
Types
Shuanghuanglian Oral Solution, Shuanghuanglian Capsule, Shuanghuanglian Lozenges, Shuanghuanglian Chewable Tablets, Shuanghuanglian Aerosol, Shuanghuanglian Injection, Shuanghuanglian Pills, Shuanghuanglian Particles, Shuanghuanglian Syrup
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Adult, Children
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Ruige Pharmaceutical
- TALOPH
- Dongguan Asia Pharmaceutical
- Harbin Pharmaceutical Group
- Xinsheng Pharmaceutical
- Jinjiu Pharmaceutical
- Fusen Pharmaceutical
- TASLY Holding
- Harbin No.4 Traditional Chinese Medicine
- ZBD Pharmaceutical
- Xiren Pharmaceutical
- Gerun Pharmaceutical
 Preparations Market Overview.svg)
Highlights of The Shuanghuanglian (SHL) Preparations Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Shuanghuanglian Oral Solution
- Shuanghuanglian Capsule
- Shuanghuanglian Lozenges
- Shuanghuanglian Chewable Tablets
- Shuanghuanglian Aerosol
- Shuanghuanglian Injection
- Shuanghuanglian Pills
- Shuanghuanglian Particles
- Shuanghuanglian Syrup
- By Application:
- Adult
- Children
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Shuanghuanglian (SHL) Preparations Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Preparations Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Shuanghuanglian (SHL) preparations are a type of Chinese herbal medicine that is used to treat a variety of health conditions. These preparations typically include extracts from various types of plants, including herbs, roots, and flowers. They may also include other ingredients such as minerals or animal products. SHL preparations are often used to improve overall health and well-being by helping to restore balance in the body's natural systems.
Some of the major players in the shuanghuanglian (shl) preparations market are Ruige Pharmaceutical, TALOPH, Dongguan Asia Pharmaceutical, Harbin Pharmaceutical Group, Xinsheng Pharmaceutical, Jinjiu Pharmaceutical, Fusen Pharmaceutical, TASLY Holding, Harbin No.4 Traditional Chinese Medicine, ZBD Pharmaceutical, Xiren Pharmaceutical, Gerun Pharmaceutical.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Shuanghuanglian (SHL) Preparations Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Shuanghuanglian (SHL) Preparations Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Shuanghuanglian (SHL) Preparations Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Shuanghuanglian (SHL) Preparations Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Shuanghuanglian (SHL) Preparations Market Size & Forecast, 2020-2028
4.5.1 Shuanghuanglian (SHL) Preparations Market Size and Y-o-Y Growth
4.5.2 Shuanghuanglian (SHL) Preparations Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Shuanghuanglian Oral Solution
5.2.2 Shuanghuanglian Capsule
5.2.3 Shuanghuanglian Lozenges
5.2.4 Shuanghuanglian Chewable Tablets
5.2.5 Shuanghuanglian Aerosol
5.2.6 Shuanghuanglian Injection
5.2.7 Shuanghuanglian Pills
5.2.8 Shuanghuanglian Particles
5.2.9 Shuanghuanglian Syrup
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Adult
6.2.2 Children
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Shuanghuanglian (SHL) Preparations Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Shuanghuanglian (SHL) Preparations Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Shuanghuanglian Oral Solution
9.6.2 Shuanghuanglian Capsule
9.6.3 Shuanghuanglian Lozenges
9.6.4 Shuanghuanglian Chewable Tablets
9.6.5 Shuanghuanglian Aerosol
9.6.6 Shuanghuanglian Injection
9.6.7 Shuanghuanglian Pills
9.6.8 Shuanghuanglian Particles
9.6.9 Shuanghuanglian Syrup
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Adult
9.10.2 Children
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Shuanghuanglian Oral Solution
10.6.2 Shuanghuanglian Capsule
10.6.3 Shuanghuanglian Lozenges
10.6.4 Shuanghuanglian Chewable Tablets
10.6.5 Shuanghuanglian Aerosol
10.6.6 Shuanghuanglian Injection
10.6.7 Shuanghuanglian Pills
10.6.8 Shuanghuanglian Particles
10.6.9 Shuanghuanglian Syrup
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Adult
10.10.2 Children
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Shuanghuanglian Oral Solution
11.6.2 Shuanghuanglian Capsule
11.6.3 Shuanghuanglian Lozenges
11.6.4 Shuanghuanglian Chewable Tablets
11.6.5 Shuanghuanglian Aerosol
11.6.6 Shuanghuanglian Injection
11.6.7 Shuanghuanglian Pills
11.6.8 Shuanghuanglian Particles
11.6.9 Shuanghuanglian Syrup
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Adult
11.10.2 Children
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Shuanghuanglian Oral Solution
12.6.2 Shuanghuanglian Capsule
12.6.3 Shuanghuanglian Lozenges
12.6.4 Shuanghuanglian Chewable Tablets
12.6.5 Shuanghuanglian Aerosol
12.6.6 Shuanghuanglian Injection
12.6.7 Shuanghuanglian Pills
12.6.8 Shuanghuanglian Particles
12.6.9 Shuanghuanglian Syrup
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Adult
12.10.2 Children
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Shuanghuanglian Oral Solution
13.6.2 Shuanghuanglian Capsule
13.6.3 Shuanghuanglian Lozenges
13.6.4 Shuanghuanglian Chewable Tablets
13.6.5 Shuanghuanglian Aerosol
13.6.6 Shuanghuanglian Injection
13.6.7 Shuanghuanglian Pills
13.6.8 Shuanghuanglian Particles
13.6.9 Shuanghuanglian Syrup
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Adult
13.10.2 Children
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Shuanghuanglian (SHL) Preparations Market: Competitive Dashboard
14.2 Global Shuanghuanglian (SHL) Preparations Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Ruige Pharmaceutical
14.3.2 TALOPH
14.3.3 Dongguan Asia Pharmaceutical
14.3.4 Harbin Pharmaceutical Group
14.3.5 Xinsheng Pharmaceutical
14.3.6 Jinjiu Pharmaceutical
14.3.7 Fusen Pharmaceutical
14.3.8 TASLY Holding
14.3.9 Harbin No.4 Traditional Chinese Medicine
14.3.10 ZBD Pharmaceutical
14.3.11 Xiren Pharmaceutical
14.3.12 Gerun Pharmaceutical
